29
/
en
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Create
Public Timelines
Library
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Download
Export
Duplicate
Embed
298 views
0
0
COVID 2021 - Policy, vaccines, therapies, and testing
Created by
MedicalGold.ca
⟶ Updated 16 Sep 2021 ⟶
List of edits
Timelines by
MedicalGold.ca
:
16 Sep 2021
0
0
553
COVID 2020 - Policy, vaccines, therapies, and testing
16 Sep 2021
0
0
212
COVID 2021 - Government
Comments
Events
January: A new, highly virulent strain of SARS-CoV-2 (the alpha variant “B.1.1.7) was first identified in a patient in New York. This variant originated in the UK. Over 60 cases are identified by the CDC during January 2021.
January 8: Joe Biden toys with the idea of cutting vaccine doses in half to speed up the rollout. This decision is not based on available science and is a pure political ploy to increase his favor in a divided nation.
January 13: CDC estimates COVID-19 vaccines have surpassed 10 million first doses in the US.
January 4: The UK begins distributing the AstraZeneca-Oxford vaccine, which can be stored in the refrigerator.
January 5: Moderna announces its plan to produce 600 million doses of their mRNA vaccine.
January 12: Pfizer-BioNTech vaccine is shown to be effective against the alpha B.1.1.7 variant.
January 20: Biden issues new COVID-19 guidance, which includes mandatory social distancing and masking in federal buildings. He also retracts the US withdrawal from the WHO.
January 26: Moderna begins to test booster shots designed to be more effective against mutations. This news comes as fear of the South African variant (B.1.351) spreads.
January 29: J&J and Novavax release positive Phase III trial results. A single dose of the J&J vaccine is 72% effective. The double-dose Novavax vaccine is 89% effective. Neither is as effective in B.1.351.
February 1: More Americans are vaccinated than infected – 26.5 million doses administered v. 26.3 million positive tests since January 2020.
February 3: o AstraZeneca-Oxford announce positive results (76% efficacy) for their vaccine in a 3-month study. An additional booster shot increases the efficacy to 82.4% after 3 months. o GlasoSmithKline partners with CureVac to accelerate vaccine production. Companies aim to produce 100 million doses of GSK’s vaccine, in Phase II trials.
February 5: J&J submits application for EUA. This vaccine is intended to be administered as a single shot, and can easily be stored in the refrigerator for up to 3 months.
February 9: The Pfizer-BioNTech vaccine neutralized 3 variants.
February 12: US purchases 200 million units of Moderna and Pfizer vaccines, bringing the total supply to 600 doses
February 19: The US pledges $4B to the Global Vaccine Effort in collaboration with the WHO and Coalition for Epidemic Preparedness.
February 21: Large-scale Israeli study finds that the Pfizer vaccine is 98.8% effective at preventing deaths and hospitalizations after 2 doses.
February 26-27: o 50 million vaccines have been administered in the US. So far 500,000 Americans have DOVID-19 related deaths. o FDA panel votes to move J&J vaccine (Phase III) forward and grants EUA, which rolls out March 1st.
March 8: CDC releases guidance for fully vaccinated individuals, suggesting that they can meet other vaccinated individuals, or unvaccinated low-risk, without masks or distancing. This policy would continuously change in a bid for Government control over the people.
March 11: Biden orders 100 million more doses of the J&J vaccine (single dose), bringing the total to 200 million doses.
March 19: US administers 100 millionth vaccine
March 14-18: Skepticism rises over the safety of the AstraZeneca vaccine, causing many European countries to halt its use. It was eventually determined that there is no causal link between the AZ vaccine and blood clots.
March 22: AstraZeneca reports 79% efficacy and no safety concerns. When questioned by the Data Safety Monitoring Board, AstraZeneca releases updated data that shows 76% efficacy.
March 29: A real-world study shows that the double-dose mRNA vaccines developed by Pfizer-BioNTech and Moderna are 90% effective in preventing SARS-CoV-2 infection. Pfizer quickly releases adolescent vaccination data showing higher levels of antibody response in children ages 12-15.
April 1: A Phase III study of Pfizer-BioNTech’s vaccine shows efficacy after 6 month and is also active against the B.1.351 (beta) South African variant.
April 7: AstraZeneca’s vaccine trial in children is paused citing blood-clotting issues reported in adults.
April 9: Pfizer-BioNTech apply for EUA expansion in adolescents.
April 13: The CDC and FDA recommend pausing J&J vaccine administration after 6 cases of thrombosis (blood clots) were reported in the US.
April 14: The European Commission ends its vaccine contracts with J&J and AstraZeneca but maintains relations with Pfizer and Moderna.
April 19: All adults in the US are now eligible to receive the vaccines.
April 20: The European medicines Agency resumes J&J vaccination. This decision is quickly followed by the CDC’s decision to lift the moratorium on the J&J vaccine.
April 27: The CDC updates mask guidance to recommend that fully vaccinated individuals do not need to wear masks unless in a crowded, indoor area.
May 5: Vaccine patents are temporarily waived to increase the global supply, allowing countries to permit compulsory licensing (Baye Dohl Act) to manufacturers. Over 250 million doses have been administered.
May 10: The Pfizer-BioNTech vaccine receives EUA approval for adolescents ages 12 to 15.
May 13: The CDC further loosens mask guidance, announcing that fully vaccinated individuals can socialize in large indoor gatherings without a mask or social distancing.
May 17: GlaxoSmithKline-Sanofi vaccine shows positive Phase II results, as measured by an induction of neutralizing antibodies similar to those found in people who recovered from the virus.
June 1: The Equal Employment Opportunity Commission issued guidance allowing employers to mandate vaccines. Employers must accommodate workers exempt from immunization under the Americans with Disabilities Act.
June 23: Fauci expresses concerns over the delta variant (B.1.617.2) which has increased in incidence, representing 20% of new infections in the preceding two weeks. The US surpasses 600,000 COVID-19 deaths.
July 6: The Israeli government reports decreasing efficacy of the Pfizer-BioNTech vaccine, a drop from 94% to 64% for the period of June 6 – early July. This is further confirmed in a study published in the New England Journal of medicine on July 21.
July 29: Biden imposes a mandate on civilian federal workers – get vaccinated or submit to routine testing. He clarifies that a mandate for all federal employees is not expected.
August 3: 70% of the US has received at least 1 dose of a COVID-19 vaccine.
August 9: Fauci suggests draconian laws upon full FDA approval of the vaccines, implying that full approval warrants schools, hospitals, and other organizations to require proof of vaccination. The Department of Defense issues a warning that mandatory vaccination is imminent.
August 18: The Biden Administration announces a booster shot plan for the general public, beginning on September 20, 2021. Boosters will be given at 8 months following the second dose of the mRNA vaccines (J&J data pending).
August 23: The Pfizer-BioNTech vaccine gains full approval by the FDA for patients 16 years and older, while adolescents aged 12 to 15 can get vaccinated under the EUA.
August 23: The Department of Defense updated their guidance to require vaccination of all servicemen. At this time, civilian federal employees must be vaccinated or submit to routine testing.
August 29: Fauci backs mandatory vaccines for school children, saying "We've done this for decades and decades, requiring polio, measles, mumps, rubella, hepatitis" vaccinations. At this time, no vaccine is approved for children under 12.
September 9: Biden mandates COVID vaccines for all federal workers, with no option for testing.
September 13: The Atlantic publishes an article claiming that ~50% of “COVID” hospitalizations are actually for other reasons. The numbers are drastically misleading.
September 14: Rochelle Walensky, CDC Director, announced on PBS that the US has donated 130 million of doses to 90 countries, and anticipates donating 200 million more internationally.
September 15: Arizona becomes first state to sue Biden administration over COVID-19 vaccine mandates. People citing “religious exemptions” to avoid compulsory vaccination grow in number, with 2,600 LAPD officers citing religious objections.
September 16: The science behind booster shots is contentious, and many experts (including two members of the FDA) are against them. Moderna’s president claims that that 28 out of 1,000 vaccinated individuals experience breakthrough infections from the delta variant.